Sem-P Therapeutic Segment: Anti-Diabetic Generic Name: Semaglutide Indication Injection 2mg/1.5ml 4mg/3ml Pre-filled Injection 2mg/1.5ml 4mg/3ml Sem-P is indicated: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Naltrexone was originally FDA-approved for treating opioid addiction (1984) and alcohol dependence (1995) and is an opioid receptor antagonist , meaning it blocks the pleasure/reward receptors in the brain
Right after the injection, you may experience mild discomfort at the injection site, such as slight redness, swelling, or tenderness
Some people on semaglutide lose 25%
When a patient taking GLP-1 medications experiences night sweats, it is essential to consider alternative explanations rather than automatically attributing the symptom to the medication
However, individual responses vary considerably, and the degree of appetite reduction differs among patients